JP2015528504A5 - - Google Patents

Download PDF

Info

Publication number
JP2015528504A5
JP2015528504A5 JP2015532043A JP2015532043A JP2015528504A5 JP 2015528504 A5 JP2015528504 A5 JP 2015528504A5 JP 2015532043 A JP2015532043 A JP 2015532043A JP 2015532043 A JP2015532043 A JP 2015532043A JP 2015528504 A5 JP2015528504 A5 JP 2015528504A5
Authority
JP
Japan
Prior art keywords
delivery system
drug delivery
level
active ingredient
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015532043A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015528504A (ja
Filing date
Publication date
Priority claimed from US13/843,718 external-priority patent/US20140073678A1/en
Application filed filed Critical
Publication of JP2015528504A publication Critical patent/JP2015528504A/ja
Publication of JP2015528504A5 publication Critical patent/JP2015528504A5/ja
Pending legal-status Critical Current

Links

JP2015532043A 2012-09-12 2013-09-12 抗疼痛及び抗嘔気及び/又は抗嘔吐組み合わせ組成物 Pending JP2015528504A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261700146P 2012-09-12 2012-09-12
US61/700,146 2012-09-12
US13/843,718 US20140073678A1 (en) 2012-09-12 2013-03-15 Anti-pain and anti-nausea and/or vomiting combinatorial compositions
US13/843,718 2013-03-15
PCT/US2013/059460 WO2014043346A2 (en) 2012-09-12 2013-09-12 Anti-pain and anti-nausea and/or vomiting combinatorial compositions

Publications (2)

Publication Number Publication Date
JP2015528504A JP2015528504A (ja) 2015-09-28
JP2015528504A5 true JP2015528504A5 (OSRAM) 2016-08-18

Family

ID=50233885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015532043A Pending JP2015528504A (ja) 2012-09-12 2013-09-12 抗疼痛及び抗嘔気及び/又は抗嘔吐組み合わせ組成物

Country Status (6)

Country Link
US (1) US20140073678A1 (OSRAM)
EP (1) EP2895145A2 (OSRAM)
JP (1) JP2015528504A (OSRAM)
AU (1) AU2013315484A1 (OSRAM)
CA (1) CA2884757A1 (OSRAM)
WO (1) WO2014043346A2 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2124556T3 (pl) 2006-10-09 2015-02-27 Charleston Laboratories Inc Kompozycje farmaceutyczne
CA3066426A1 (en) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
US20140275194A1 (en) * 2013-03-15 2014-09-18 Monosol Rx, Llc Films and drug delivery systems for rizatriptan
EP3160589B1 (en) 2014-06-24 2023-10-25 TAHO Pharmaceuticals Ltd. Fast acting orally disintegrating film
DE202015006313U1 (de) * 2014-09-09 2016-02-02 Charleston Laboratories, Inc. Pharmazeutische Zusammensetzungen
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2018269557B2 (en) 2017-05-17 2021-06-03 Confluence Pharmaceuticals, Llc Formulations of homotaurines and salts thereof
EP3691610A1 (en) * 2017-10-07 2020-08-12 Zim Laboratories Limited Process for the preparation of bi/multi-layer film, multi-layered film produced thereof and apparatus for producing such multi-layer films
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
WO2022104234A1 (en) * 2020-11-15 2022-05-19 Castor Trevor P Methods for assaying and measuring the efficacy of anti-nausea compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001039836A1 (en) * 1999-12-01 2001-06-07 Natco Pharma Limited A rapid acting freeze dired oral pharmaceutical composition for treating migraine
US20090232898A1 (en) * 2005-03-28 2009-09-17 Anders Pettersson Pharmaceutical Compositions Useful in the Treatment of Migraine
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
CA2664986C (en) * 2006-10-02 2015-09-22 Labtec Gesellschaft Fuer Technologische Forschung Und Entwicklung Mbh Non-mucoadhesive film dosage forms
ES2527448T3 (es) * 2008-04-28 2015-01-23 Zogenix, Inc. Nuevas formulaciones para el tratamiento de la migraña
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US20100297232A1 (en) * 2009-05-19 2010-11-25 Monosol Rx, Llc Ondansetron film compositions
DK2952191T3 (en) * 2009-06-12 2018-12-10 Sunovion Pharmaceuticals Inc Sublingual apomorphine
CA2767576C (en) * 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
CN102028672B (zh) * 2010-09-29 2012-08-29 上海现代药物制剂工程研究中心有限公司 微孔海绵状药膜制剂及其制备方法

Similar Documents

Publication Publication Date Title
JP2015528504A5 (OSRAM)
JP2009536147A5 (OSRAM)
Mercadante Pharmacotherapy for breakthrough cancer pain
JP2009539761A5 (OSRAM)
JP2019156859A5 (OSRAM)
JP2012513955A5 (OSRAM)
ES2214649T3 (es) Preparado farmaceutico plano para la administracion o liberacion, en la cavidad bucal, de buprenorfina o una sustancia comparable farmacologicamente, y metodo para la produccion del mismo.
JP2022180461A5 (OSRAM)
JP2009544619A5 (OSRAM)
US20130153459A1 (en) Package
CN102933199A (zh) 含有烟碱的药物组合物
BRPI0711168A2 (pt) composição transmucosal
WO2007095600A3 (en) Disintegrable oral films
JP2011525536A5 (OSRAM)
JP2012502015A5 (OSRAM)
WO2008035020A2 (fr) Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
CA2489106A1 (en) Film-shaped mucoadhesive administration form for administering cannabis active ingredients
ATE486593T1 (de) Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack
JP2013528588A (ja) ニコチン含有医薬組成物
RU2008130763A (ru) Сублингвальный аэрозоль на основе фентанила
JP2009543885A5 (OSRAM)
RU2301671C2 (ru) Чрескожные или чресслизистые лекарственные формы для избавления от привычки к курению в виде сочетания действующих веществ, содержащего никотин
WO2010020856A3 (en) Rate modulated delivery of drugs from a composite delivery system
Lucas et al. Recent advances in pharmacotherapy for cancer pain management
RU2008105825A (ru) Невыплевываемая, быстро распадающаяся пленка для орального применения, содержащая противорвотное средство или средство против мигрени